Schwartz makes a number of claims regarding our methodology ([@b14-ehp0114-a00400]) that are inaccurate and based on a selective reading of the literature.

In our article ([@b14-ehp0114-a00400]), we estimated the health and economic consequences of prenatal methylmercury (MeHg) exposure in the 2000 U.S. birth cohort. Our major findings were that at least 316,588 children in that birth cohort suffered IQ (intelligence quotient) loss of 0.2--24.4 points as a result of MeHg toxicity sustained *in utero*. This loss of intelligence causes diminished economic productivity that will persist, and this lost productivity is the major monetary consequence of methylmercury toxicity. We used the most up-to-date publicly available data on mercury exposures and health outcomes, applied a risk assessment approach developed by the National Research Council ([@b12-ehp0114-a00400]), and made conservative assumptions throughout.

To compute decrements in IQ that resulted from prenatal mercury exposures, we used data from [@b8-ehp0114-a00400] on percentages of women of childbearing age in 1999--2000 with mercury concentrations ≥ 3.5, 4.84, 5.8, 7.13, and 15.0 μg/L. These data most closely reflect exposure to women in the years 1999--2000, when toxicity to the developing brains of children in the 2000 birth cohort would have occurred. We then applied logarithmic and linear models to these data, and we calculated a range of IQ decrements for each subpopulation born with a cord blood mercury concentration \> 5.8 μg/L. To assess a range of possible outcomes, we conducted a sensitivity analysis in which we applied a range of IQ decrements for each increase in mercury concentration. We described our methods in great detail ([@b14-ehp0114-a00400]). Through this series of calculations, we generated upper and lower ranges of possible IQ decrements for each subpopulation among the most highly exposed children in the 2000 U.S. birth cohort.

In his letter, Schwartz asserts that it is impossible to impute effects on children's intelligence of prenatal exposures to mercury near the U.S. Environmental Protection Agency's (EPA) reference dose (RfD). In proffering this assertion, he appears to ignore a recent meta-analysis of the three studies that confirmed a dose--response relationship between low-level prenatal MeHg exposure and IQ ([@b2-ehp0114-a00400]). A recent U.S. cohort study has also detected decrements in visual recognition memory among children exposed prenatally to MeHg ([@b11-ehp0114-a00400]).

Schwartz suggests that we should have used the U.S. EPA benchmark dose level (BMDL) of 58 μg/L as a cutoff. He apparently assumes that no injury occurs to fetal brains from exposure to MeHg below that level. That approach does not reflect biologic or epidemiologic reality. We based our selection of 5.8 μg/L as a no adverse effect level on the epidemiologic evidence, not on the U.S. EPA's regulatory documents ([@b1-ehp0114-a00400]; [@b4-ehp0114-a00400]; [@b5-ehp0114-a00400] Kjellstrom et al. 1989). We relied especially upon the NRC's report on prenatal exposure to MeHg ([@b13-ehp0114-a00400]), which concluded that the likelihood of subnormal scores on neuro-developmental tests increased as cord blood mercury concentrations increased from levels as low as 5 μg/L. Methylmercury exposure has also been associated with persistent delays in peak I--III brainstem-evoked potentials at cord blood levels \< 5 μg/L ([@b10-ehp0114-a00400]).

Schwartz misrepresents [@b3-ehp0114-a00400], stating that they "superseded previous reports and found no IQ reduction." In fact, the [@b13-ehp0114-a00400] stated that Crump et al.

> reported nonsignificant results from a regression analysis on all the children in the New Zealand cohort, but \[that these results became significant\] after omission of a single child whose mother's hair Hg concentration was 86 ppm (4 times higher than that of the next highest exposure level in the study).

Schwartz misrepresents our characterization of the Seychelles Islands study ([@b7-ehp0114-a00400]; [@b9-ehp0114-a00400]), accusing us of stating that it had half the statistical power of the Faroe Islands study ([@b4-ehp0114-a00400]). In actuality, we stated that the Seychelles study "had only 50% statistical power to detect the effects observed in the Faroes" ([@b14-ehp0114-a00400]). Schwartz asserts that the NRC's choice not to apply the Seychelles data in setting an RfD represents equivocation about the health effects of MeHg. In actuality, the NRC came to the same conclusion as we did: "\[t\]he weight of the evidence of developmental neurotoxic effects from exposure to MeHg is strong" ([@b13-ehp0114-a00400]).

Recent work ([@b15-ehp0114-a00400]) suggests that our calculation of the economic costs ([@b14-ehp0114-a00400]) may, in fact, be an underestimate. The new study indicates that downward shifts in IQ are also associated with thousands of excess cases of mental retardation (defined as IQ \< 70) in the United States each year. Care of these children is associated with needs for health care, special education, and other services that impose a great burden on society.

All of these adverse consequences can be prevented by prevention of prenatal exposure to MeHg.
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